Filing Details
- Accession Number:
- 0001209191-20-006284
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-04 16:11:35
- Reporting Period:
- 2020-01-31
- Accepted Time:
- 2020-02-04 16:11:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1334365 | Yuchun Lee | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-01-31 | 200 | $224.03 | 4,647 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-31 | 206 | $225.10 | 4,441 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-31 | 823 | $226.64 | 3,618 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-31 | 171 | $227.54 | 3,447 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-31 | 100 | $230.04 | 3,347 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-31 | 300 | $232.51 | 3,047 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-31 | 200 | $233.37 | 2,847 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-03 | 423 | $229.39 | 2,424 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-03 | 421 | $230.69 | 2,003 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-03 | 956 | $231.70 | 1,047 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-03 | 200 | $232.69 | 847 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $224.03 (range $223.64 to $224.42).
- Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $225.10 (range $225.03 to $225.46).
- Open market sales reported on this line occurred at a weighted average price of $226.64 (range $226.21 to $227.16).
- Open market sales reported on this line occurred at a weighted average price of $227.54 (range $227.41 to $227.63).
- Open market sales reported on this line occurred at a weighted average price of $232.51 (range $231.93 to $232.90).
- Open market sales reported on this line occurred at a weighted average price of $233.37 (range $233.12 to $233.61).
- Open market sales reported on this line occurred at a weighted average price of $229.39 (range $229.16 to $229.93).
- Open market sales reported on this line occurred at a weighted average price of $230.69 (range $230.26 to $231.19).
- Open market sales reported on this line occurred at a weighted average price of $231.70 (range $231.31 to $232.28).
- Open market sales reported on this line occurred at a weighted average price of $232.69 (range $232.67 to $232.70).
Billionaire Hedge Funds
